MASH disease: From silent epidemic to treatment options
Liver disease is a growing global health concern, yet many of its most serious forms remain...
Liver disease is a growing global health concern, yet many of its most serious forms remain...
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
As therapies become increasingly complex and personalized, it is imperative that physicians...
Liver disease is a growing global health concern, yet many of its most serious forms remain under-recognized and underdiagnosed. Metabolic dysfunction-associated steatohepatitis (MASH) stands out as a particularly urgent challenge. MASH disease is a ...